Recent draft rules in India threaten advancements in non-animal testing for drug development and safety. The new regulations may prioritize...

Wockhardt has expanded its marketing access for Miqnaf in India following the removal of a supply condition. The company's biotechnology se...

Knowledge Marine shares gained 4.17% after securing a Rs 303.17 crore, three-year maintenance dredging contract from New Mangalore Port Aut...

Over the past four quarters, India's medicine sales have increased significantly due to rising demand in chronic care segments. The growth ...

From a pancreatic cancer drug that targets KRAS mutations to a smarter power wheelchair, University of California research is reaching beyo...

In a significant move, the Karnataka government declared it would not proceed with a disputed circular aimed at mandating hospitals to disc...

Indian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...

The Bombay High Court has ordered the removal of Shreya Life Sciences’ antibiotic trademark Lefoxin Biox from the register, ruling that it ...

Nearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across ...

The Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...

India should examine trade margins across medicines, medical devices and consumables using a common, scientifically credible method - not a...

Prices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...

India has capped trade margins at 30% on 137 non-scheduled anti-cancer drugs to reduce treatment costs. Experts call for standardised care,...

The Supreme Court expressed concern over the government's role in allowing steep medicine prices to persist. Justices Vikram Nath and Sande...

Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...

Govt has told Supreme Court that hospitals overcharging patients for medicines and medical consumables is a malpractice. Its affidavit cite...

India's National Pharmaceutical Pricing Authority has capped trade margins for 137 anti-cancer drugs at 30% of their maximum retail price. ...